The vascular grafts market size has grown strongly in recent years. It will grow from $3.86 billion in 2025 to $4.1 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rise in bypass surgeries, advancements in synthetic and biological graft materials, expanding hospital and cardiac surgery infrastructure, growing awareness of vascular disorders.
The vascular grafts market size is expected to see strong growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of tissue-engineered grafts, AI-driven patient-specific graft design, growth in minimally invasive surgery, integration with intraoperative imaging, increasing geriatric population requiring vascular interventions. Major trends in the forecast period include bioengineered and tissue-engineered grafts, ai-assisted graft design, minimally invasive implant techniques, integration with imaging and monitoring systems, customized patient-specific grafts.
The rising incidence of cardiovascular diseases is increasingly supporting the expansion of the vascular grafts market going forward. Cardiovascular diseases include a group of disorders affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The increase in cardiovascular diseases is largely associated with unhealthy dietary habits, including excessive consumption of processed foods and fats that elevate cholesterol levels and cardiovascular risk. Vascular grafts play a critical role in cardiovascular treatment by bypassing or replacing damaged blood vessels, improving blood circulation, and reducing complication risks. These grafts enhance patient outcomes by enabling effective surgical interventions and supporting long-term cardiovascular health. For example, in October 2024, according to the Centers for Disease Control, a US-based government agency, approximately 919,032 deaths in 2023 were attributed to cardiovascular disease, accounting for one in every three deaths. As a result, the rising incidence of cardiovascular diseases is strengthening demand for vascular grafts.
Leading companies operating in the vascular grafts market are focused on introducing innovative products to strengthen their competitive position. Innovative products in this market involve advanced technologies designed to improve treatment of vascular disorders and overcome limitations of traditional grafts. For example, in January 2023, Viz.ai, a US-based medical technology company, launched the AI-powered Viz Vascular Suite. The platform uses artificial intelligence to analyze imaging data such as CT and ECG scans for suspected vascular disease and automatically alerts care teams, enabling rapid, coordinated, and HIPAA-compliant communication among specialists.
In April 2025, Healthcare Holding Switzerland AG, a Switzerland-based medical technology services provider, acquired Schaublin Medica SA for an undisclosed amount. With this acquisition, Healthcare Holding aims to reinforce its cardiovascular and vascular surgery portfolio by integrating Schaublin Medica’s expertise in vascular grafts, endoprostheses, stents, and drug-coated balloon catheter technologies. Schaublin Medica SA is a Switzerland-based cardiovascular medical device company specializing in vascular graft solutions.
Major companies operating in the vascular grafts market are B. Braun Melsungen AG, Abbott Laboratories, W. L. Gore & Associates Inc., Terumo Medical Corporation, Medtronic Plc, Endologix, Cook Medical, MicroPort, CR Bard, Biovic, Novomed Incorporation Private Limited, Gore Medical, LeMaitre Vascular, JOTEC, Vascutek, RUA Life Sciences, Vascular Flow Technologies, Bolton Medical, Cryolife, Vascular Graft Solutions Ltd.
North America was the largest region in the vascular grafts market in 2025. Western Europe was the second largest region in the vascular grafts market report. The regions covered in the vascular grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on imported synthetic graft materials, biological scaffolds, and delivery systems have increased device costs. Regions heavily reliant on imports, such as Europe and North America, have encouraged domestic manufacturing of vascular grafts, accelerating innovation in bioengineered grafts.
The vascular grafts market research report is one of a series of new reports that provides vascular grafts market statistics, including vascular grafts industry global market size, regional shares, competitors with a vascular grafts market share, detailed vascular grafts market segments, market trends and opportunities, and any further data you may need to thrive in the vascular grafts industry. This vascular grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular grafts are used to repair damaged or blocked blood vessels during surgical procedures such as vascular grafting or bypass surgery. The graft redirects blood flow around partially or fully blocked arteries, improving circulation by rerouting blood to healthy vessels.
The main products in the vascular grafts market include hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery bypass grafts. Endovascular stent grafts are minimally invasive solutions used to treat aortic aneurysms and are employed to assess abdominal pain, disease-related symptoms, and aneurysm size. The raw materials used include polyester grafts, expanded polytetrafluoroethylene (ePTFE), polyurethane grafts, and biosynthetic grafts. The applications include coronary artery disease, aneurysms, vascular occlusions, and renal failure, and these grafts are used by end users such as hospitals and ambulatory surgical centers.
The vascular grafts market consists of sales of polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vascular grafts market size is expected to see strong growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of tissue-engineered grafts, AI-driven patient-specific graft design, growth in minimally invasive surgery, integration with intraoperative imaging, increasing geriatric population requiring vascular interventions. Major trends in the forecast period include bioengineered and tissue-engineered grafts, ai-assisted graft design, minimally invasive implant techniques, integration with imaging and monitoring systems, customized patient-specific grafts.
The rising incidence of cardiovascular diseases is increasingly supporting the expansion of the vascular grafts market going forward. Cardiovascular diseases include a group of disorders affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The increase in cardiovascular diseases is largely associated with unhealthy dietary habits, including excessive consumption of processed foods and fats that elevate cholesterol levels and cardiovascular risk. Vascular grafts play a critical role in cardiovascular treatment by bypassing or replacing damaged blood vessels, improving blood circulation, and reducing complication risks. These grafts enhance patient outcomes by enabling effective surgical interventions and supporting long-term cardiovascular health. For example, in October 2024, according to the Centers for Disease Control, a US-based government agency, approximately 919,032 deaths in 2023 were attributed to cardiovascular disease, accounting for one in every three deaths. As a result, the rising incidence of cardiovascular diseases is strengthening demand for vascular grafts.
Leading companies operating in the vascular grafts market are focused on introducing innovative products to strengthen their competitive position. Innovative products in this market involve advanced technologies designed to improve treatment of vascular disorders and overcome limitations of traditional grafts. For example, in January 2023, Viz.ai, a US-based medical technology company, launched the AI-powered Viz Vascular Suite. The platform uses artificial intelligence to analyze imaging data such as CT and ECG scans for suspected vascular disease and automatically alerts care teams, enabling rapid, coordinated, and HIPAA-compliant communication among specialists.
In April 2025, Healthcare Holding Switzerland AG, a Switzerland-based medical technology services provider, acquired Schaublin Medica SA for an undisclosed amount. With this acquisition, Healthcare Holding aims to reinforce its cardiovascular and vascular surgery portfolio by integrating Schaublin Medica’s expertise in vascular grafts, endoprostheses, stents, and drug-coated balloon catheter technologies. Schaublin Medica SA is a Switzerland-based cardiovascular medical device company specializing in vascular graft solutions.
Major companies operating in the vascular grafts market are B. Braun Melsungen AG, Abbott Laboratories, W. L. Gore & Associates Inc., Terumo Medical Corporation, Medtronic Plc, Endologix, Cook Medical, MicroPort, CR Bard, Biovic, Novomed Incorporation Private Limited, Gore Medical, LeMaitre Vascular, JOTEC, Vascutek, RUA Life Sciences, Vascular Flow Technologies, Bolton Medical, Cryolife, Vascular Graft Solutions Ltd.
North America was the largest region in the vascular grafts market in 2025. Western Europe was the second largest region in the vascular grafts market report. The regions covered in the vascular grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on imported synthetic graft materials, biological scaffolds, and delivery systems have increased device costs. Regions heavily reliant on imports, such as Europe and North America, have encouraged domestic manufacturing of vascular grafts, accelerating innovation in bioengineered grafts.
The vascular grafts market research report is one of a series of new reports that provides vascular grafts market statistics, including vascular grafts industry global market size, regional shares, competitors with a vascular grafts market share, detailed vascular grafts market segments, market trends and opportunities, and any further data you may need to thrive in the vascular grafts industry. This vascular grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular grafts are used to repair damaged or blocked blood vessels during surgical procedures such as vascular grafting or bypass surgery. The graft redirects blood flow around partially or fully blocked arteries, improving circulation by rerouting blood to healthy vessels.
The main products in the vascular grafts market include hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery bypass grafts. Endovascular stent grafts are minimally invasive solutions used to treat aortic aneurysms and are employed to assess abdominal pain, disease-related symptoms, and aneurysm size. The raw materials used include polyester grafts, expanded polytetrafluoroethylene (ePTFE), polyurethane grafts, and biosynthetic grafts. The applications include coronary artery disease, aneurysms, vascular occlusions, and renal failure, and these grafts are used by end users such as hospitals and ambulatory surgical centers.
The vascular grafts market consists of sales of polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vascular Grafts Market Characteristics
3. Vascular Grafts Market Supply Chain Analysis
4. Global Vascular Grafts Market Trends and Strategies
5. Vascular Grafts Market Analysis of End Use Industries
7. Global Vascular Grafts Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vascular Grafts Total Addressable Market (TAM) Analysis for the Market
9. Vascular Grafts Market Segmentation
10. Vascular Grafts Market Regional and Country Analysis
11. Asia-Pacific Vascular Grafts Market
12. China Vascular Grafts Market
13. India Vascular Grafts Market
14. Japan Vascular Grafts Market
15. Australia Vascular Grafts Market
16. Indonesia Vascular Grafts Market
17. South Korea Vascular Grafts Market
18. Taiwan Vascular Grafts Market
19. South East Asia Vascular Grafts Market
20. Western Europe Vascular Grafts Market
21. UK Vascular Grafts Market
22. Germany Vascular Grafts Market
23. France Vascular Grafts Market
24. Italy Vascular Grafts Market
25. Spain Vascular Grafts Market
26. Eastern Europe Vascular Grafts Market
27. Russia Vascular Grafts Market
28. North America Vascular Grafts Market
29. USA Vascular Grafts Market
30. Canada Vascular Grafts Market
31. South America Vascular Grafts Market
32. Brazil Vascular Grafts Market
33. Middle East Vascular Grafts Market
34. Africa Vascular Grafts Market
36. Vascular Grafts Market Competitive Landscape and Company Profiles
37. Vascular Grafts Market Other Major and Innovative Companies
40. Vascular Grafts Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vascular Grafts Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vascular grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vascular grafts? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular grafts market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Hemodialysis Access Graft; Endovascular Stent Graft; Peripheral Vascular Graft; Coronary Artery By-Pass Graft2) By Raw Material: Polyester Grafts; Polytetrafluoroethylene Grafts; Polyurethane Grafts; Biosynthetic Grafts
3) By Application: Coronary Artery Disease; Aneurysm; Vascular Occlusion; Renal Failure
4) By End-User: Hospitals; Ambulatory Surgical Centers
Subsegments:
1) By Hemodialysis Access Graft: Synthetic Grafts; Biological Grafts2) By Endovascular Stent Graft: Aneurysm Stent Grafts; Thoracic Stent Grafts; Abdominal Stent Grafts
3) By Peripheral Vascular Graft: Synthetic Grafts; Biological Grafts
4) By Coronary Artery Bypass Graft (Cabg): Arterial Grafts; Venous Grafts
Companies Mentioned: B. Braun Melsungen AG; Abbott Laboratories; W. L. Gore & Associates Inc.; Terumo Medical Corporation; Medtronic Plc; Endologix; Cook Medical; MicroPort; CR Bard; Biovic; Novomed Incorporation Private Limited; Gore Medical; LeMaitre Vascular; JOTEC; Vascutek; RUA Life Sciences; Vascular Flow Technologies; Bolton Medical; Cryolife; Vascular Graft Solutions Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vascular Grafts market report include:- B. Braun Melsungen AG
- Abbott Laboratories
- W. L. Gore & Associates Inc.
- Terumo Medical Corporation
- Medtronic Plc
- Endologix
- Cook Medical
- MicroPort
- CR Bard
- Biovic
- Novomed Incorporation Private Limited
- Gore Medical
- LeMaitre Vascular
- JOTEC
- Vascutek
- RUA Life Sciences
- Vascular Flow Technologies
- Bolton Medical
- Cryolife
- Vascular Graft Solutions Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.1 Billion |
| Forecasted Market Value ( USD | $ 5.35 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
